Literature DB >> 15128486

Management of esophageal varices: an update from Digestive Disease Week and American Association for the Study of Liver Diseases 2003.

Samer Gawrieh1, Kia Saeian.   

Abstract

Esophageal varices are a commonly encountered complication of cirrhosis. beta-blockers are a well-established cornerstone of the treatment of portal hypertension and primary and secondary prophylaxis for prevention of esophageal variceal bleeding. However, not all patients tolerate this type of therapy. Moreover, the exact role of esophageal variceal band ligation alone or in combination with beta-blocker therapy in the management of patients with esophageal varices remains to be defined. This summary report presents a number of recent studies addressing these important issues.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15128486     DOI: 10.1007/s11894-004-0008-3

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  15 in total

1.  Portal hypertension and variceal bleeding: an AASLD single topic symposium.

Authors:  N D Grace; R J Groszmann; G Garcia-Tsao; A K Burroughs; L Pagliaro; R W Makuch; J Bosch; G V Stiegmann; J M Henderson; R de Franchis; J L Wagner; H O Conn; J Rodes
Journal:  Hepatology       Date:  1998-09       Impact factor: 17.425

2.  Risk factors for the presence of varices in cirrhotic patients without a history of variceal hemorrhage.

Authors:  A Zaman; T Becker; J Lapidus; K Benner
Journal:  Arch Intern Med       Date:  2001-11-26

3.  Prediction of esophageal varices in patients with cirrhosis.

Authors:  Ravi Madhotra; Hugh E Mulcahy; Ira Willner; Adrian Reuben
Journal:  J Clin Gastroenterol       Date:  2002-01       Impact factor: 3.062

4.  The treatment of portal hypertension: a meta-analytic review.

Authors:  G D'Amico; L Pagliaro; J Bosch
Journal:  Hepatology       Date:  1995-07       Impact factor: 17.425

5.  Preventive therapy of first gastrointestinal bleeding in patients with cirrhosis: results of a controlled trial comparing propranolol, endoscopic sclerotherapy and placebo.

Authors:  T Andreani; R E Poupon; B J Balkau; J C Trinchet; J D Grange; N Peigney; M Beaugrand; R Poupon
Journal:  Hepatology       Date:  1990-12       Impact factor: 17.425

6.  Factors predicting the presence of esophageal or gastric varices in patients with advanced liver disease.

Authors:  A Zaman; R Hapke; K Flora; H R Rosen; K Benner
Journal:  Am J Gastroenterol       Date:  1999-11       Impact factor: 10.864

7.  Endoscopic variceal ligation plus nadolol and sucralfate compared with ligation alone for the prevention of variceal rebleeding: a prospective, randomized trial.

Authors:  G H Lo; K H Lai; J S Cheng; M H Chen; H C Huang; P I Hsu; C K Lin
Journal:  Hepatology       Date:  2000-09       Impact factor: 17.425

8.  Which patients with cirrhosis should undergo endoscopic screening for esophageal varices detection?

Authors:  F Schepis; C Cammà; D Niceforo; A Magnano; S Pallio; M Cinquegrani; G D'amico; L Pasta; A Craxì; A Saitta; G Raimondo
Journal:  Hepatology       Date:  2001-02       Impact factor: 17.425

9.  Bacteremia after endoscopic band ligation of esophageal varices.

Authors:  C C Tseng; R M Green; S K Burke; P J Connors; D L Carr-Locke
Journal:  Gastrointest Endosc       Date:  1992 May-Jun       Impact factor: 9.427

10.  Banding ligation versus nadolol and isosorbide mononitrate for the prevention of esophageal variceal rebleeding.

Authors:  Gin-Ho Lo; Wen-Chi Chen; Mei-Hsiu Chen; Ping-I Hsu; Chiun-Ku Lin; Wei-Lun Tsai; Kwok-Hung Lai
Journal:  Gastroenterology       Date:  2002-09       Impact factor: 22.682

View more
  1 in total

1.  Long-term outcomes of endoscopic variceal ligation to prevent rebleeding in children with esophageal varices.

Authors:  Ki Soo Kang; Hye Ran Yang; Jae Sung Ko; Jeong Kee Seo
Journal:  J Korean Med Sci       Date:  2013-10-31       Impact factor: 2.153

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.